Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Intervention1: Diclofenac Transdermal Patches 100mg: After obtaining informed written consent and detailed case history from the patients, the patient will undergo phase-I therapy. After phase-I thera
the patient will be advised to change the transdermal patch after 24 and 48 hours respectively. The patients would be advised to assess the pain perception at 2,4,8 and 12 hours by himself using the V
Sponsors
Dr Anushka G Jain
Eligibility
Inclusion criteria
Inclusion criteria: Systemically healthy individuals Patient undergoing any major periodontal surgical procedure [ranging from 45- 90 mins] Patient undergoing implant surgeries/Implant second stage surgery Patients willing to participate in the study
Exclusion criteria
Exclusion criteria: Patients having gastritis/peptic ulcer. Patients with known hypersensitivity to the medications Patients on long term medications. Pregnant or lactating women. Patients not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-Operative Pain Intensity Measurement Using Vas Scale Analgesic Efficacy Of Oral Diclofenac Tablets And Diclofenac Transdermal Patch Timepoint: At Baseline , 24hours, 48 Hours and 72 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidenceof Adverse Effects Like Gastric Irritation Patient Satisfaction Score Local Tissue Reaction At Transdermal Patch Apllication Site Timepoint: At Baseline, 24 hours, 48 hours & 72 hours | — |
Countries
India
Contacts
Public ContactDr Anuradha Bhatsange
Jawahar Medical Foundations Annasaheb Chudaman Patil Memorial Dental College,Sakri Road,Dhule
Outcome results
None listed